News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Scientists identify cause of resistance to breakthrough breast and ovarian cancer drug
The study findings could help predict which patients will develop resistance to PARP inhibitors and allow doctors to alter treatment at the earliest possible opportunity.
.png?sfvrsn=e5be7df6_2 "Cell division (green 4.3)")
Major study gives vital new understandings of how cells divide
The ground-breaking research used mathematical models and pain-staking experiments to clarify the role of a key phase of cell division.
Targeting chemotherapy with genetic testing provides effective treatment for women with aggressive breast cancer
Women with an aggressive form of breast cancer who have faults in their BRCA genes do much better on chemotherapy drug carboplatin than standard treatment, a major clinical trial reports.
Researchers find five sub-types of the brain cancer glioma
The findings come from the largest ever genetic study its kind on glioma and could help us understand the biological mechanisms that trigger the disease.
Good luck to our #teamICR 2018 London marathon team
This year 22 people are joining #teamICR to run the London marathon to raise funds for cancer research. We wish all of our runners the best of luck!
Scans could guide drug treatment in breast cancer
A new scan could help doctors to spot when women with breast cancer stop responding to targeted drugs.
Professor Johann de Bono given 2018 AACR award for outstanding achievement
The ICR's Professor Johann de Bono has been chosen to receive the 2018 AACR–Joseph H. Burchenal Memorial Award for Outstanding Achievement in Clinical Cancer Research.
Scientists uncover 80 potential lines of attack against prostate cancer
Scientists have identified 80 molecular weaknesses in prostate cancer that could be targeted by drugs – in the largest, most comprehensive study ever conducted into the genes that drive the disease.
ICR hosts discussion on gender equality for UK research institutes
The Institute of Cancer Research, London, hosted a conference, specifically for research institutes, on how to improve gender equality within the workplace in Chelsea at the end of March.
Researchers discover 40 genes involved in early development of myeloma
Researchers have revealed 40 genes involved in the development of myeloma, increasing our understanding of the complex genetics behind the incurable blood cancer.
Two single-letter DNA changes could raise risk of childhood leukaemia
The team analysed genetic data from almost 2,500 people with, and more than 14,500 without, the disease to identify the differences that are associated with a greater risk.
Scientists map the genetic evolution of childhood leukaemia
The key genetic events responsible for initiating the early stages of a type of childhood leukaemia have been identified by ICR scientists.
